Moore XL - Search Results

1

Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats.

Lekgabe ED, Kiriazis H, Zhao C, Xu Q, Moore XL, Su Y, Bathgate RA, Du XJ, Samuel CS. Lekgabe ED, et al. Among authors: moore xl. Hypertension. 2005 Aug;46(2):412-8. doi: 10.1161/01.HYP.0000171930.00697.2f. Epub 2005 Jun 20. Hypertension. 2005. PMID: 15967869

2

The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs.

Lekgabe ED, Royce SG, Hewitson TD, Tang ML, Zhao C, Moore XL, Tregear GW, Bathgate RA, Du XJ, Samuel CS. Lekgabe ED, et al. Among authors: moore xl. Endocrinology. 2006 Dec;147(12):5575-83. doi: 10.1210/en.2006-0533. Epub 2006 Aug 24. Endocrinology. 2006. PMID: 16935837

3

Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.

Gao XM, Wong G, Wang B, Kiriazis H, Moore XL, Su YD, Dart A, Du XJ. Gao XM, et al. Among authors: moore xl. J Hypertens. 2006 Aug;24(8):1663-70. doi: 10.1097/01.hjh.0000239304.01496.83. J Hypertens. 2006. PMID: 16877971

4

Reversal of cardiac fibrosis and related dysfunction by relaxin.

Du XJ, Xu Q, Lekgabe E, Gao XM, Kiriazis H, Moore XL, Dart AM, Tregear GW, Bathgate RA, Samuel CS. Du XJ, et al. Among authors: moore xl. Ann N Y Acad Sci. 2009 Apr;1160:278-84. doi: 10.1111/j.1749-6632.2008.03780.x. Ann N Y Acad Sci. 2009. PMID: 19416203

5

Regression of pressure overload-induced left ventricular hypertrophy in mice.

Gao XM, Kiriazis H, Moore XL, Feng XH, Sheppard K, Dart A, Du XJ. Gao XM, et al. Among authors: moore xl. Am J Physiol Heart Circ Physiol. 2005 Jun;288(6):H2702-7. doi: 10.1152/ajpheart.00836.2004. Epub 2005 Jan 21. Am J Physiol Heart Circ Physiol. 2005. PMID: 15665058 Free article.

6

Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.

Du XJ, Gao XM, Kiriazis H, Moore XL, Ming Z, Su Y, Finch AM, Hannan RA, Dart AM, Graham RM. Du XJ, et al. Among authors: moore xl. Cardiovasc Res. 2006 Sep 1;71(4):735-43. doi: 10.1016/j.cardiores.2006.06.015. Epub 2006 Jun 16. Cardiovasc Res. 2006. PMID: 16859660

7

Relaxin antagonizes hypertrophy and apoptosis in neonatal rat cardiomyocytes.

Moore XL, Tan SL, Lo CY, Fang L, Su YD, Gao XM, Woodcock EA, Summers RJ, Tregear GW, Bathgate RA, Du XJ. Moore XL, et al. Endocrinology. 2007 Apr;148(4):1582-9. doi: 10.1210/en.2006-1324. Epub 2007 Jan 4. Endocrinology. 2007. PMID: 17204550

8

Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction.

Fang L, Gao XM, Moore XL, Kiriazis H, Su Y, Ming Z, Lim YL, Dart AM, Du XJ. Fang L, et al. Among authors: moore xl. J Mol Cell Cardiol. 2007 Nov;43(5):535-44. doi: 10.1016/j.yjmcc.2007.06.011. Epub 2007 Jul 10. J Mol Cell Cardiol. 2007. PMID: 17689559

9

Diverse regulation of cardiac expression of relaxin receptor by α1- and β1-adrenoceptors.

Moore XL, Su Y, Fan Y, Zhang YY, Woodcock EA, Dart AM, Du XJ. Moore XL, et al. Cardiovasc Drugs Ther. 2014 Jun;28(3):221-8. doi: 10.1007/s10557-014-6525-x. Cardiovasc Drugs Ther. 2014. PMID: 24852484

10

Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo.

Fang L, Moore XL, Gao XM, Dart AM, Lim YL, Du XJ. Fang L, et al. Among authors: moore xl. Life Sci. 2007 May 16;80(23):2154-2160. doi: 10.1016/j.lfs.2007.04.003. Epub 2007 Apr 21. Life Sci. 2007. PMID: 17499311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters